Dare Bioscience Inc (DARE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1.72 | -160.825 | -151.573 | -197.158 | -365.493 | -122.15 | -62.124 | -92.649 |
Return on Equity (%) | -2.802 | -182.849 | -167.231 | -420.064 | 7707.736 | -205.819 | -124.125 | -994.756 |
Return on Invested Capital (%) | -2.091 | -62.214 | -124.96 | -467.079 | 3787.422 | -210.927 | -127.235 | -1532.821 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -309.48 | -1074.11 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -309.48 | -1074.11 |
Book Value Per Share | -0.025 | 1.34 | 0.589 | 0.022 | -0.028 | 0.462 | 0.131 | -0.051 |
Earnings Per Share | -0.023 | -1.902 | -1.466 | -0.765 | -0.659 | -0.461 | -0.365 | -0.306 |
Cash Per Share | 0.002 | 1.25 | 0.596 | 0.243 | 0.112 | 0.616 | 0.409 | 0.106 |
Working Capital Per Share | -0.025 | 1.221 | 0.538 | 0.042 | -0.016 | 0.467 | 0.135 | -0.03 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.118 | 0.028 |
EBIT Per Share | -0.023 | -1.902 | -1.466 | -0.725 | -0.659 | -0.461 | -0.365 | -0.306 |
EBITDA Per Share | -0.023 | -1.902 | -1.466 | -0.725 | -0.659 | -0.461 | -0.365 | -0.306 |
Free Cash Flow Per Share | -0.023 | -1.902 | -1.465 | -0.765 | -0.659 | -0.461 | -0.364 | -0.3 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 28,94M | 6,05M | 11,42M | 19,68M | 41,6M | 83,94M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 84,83M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -75055.556 | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -75055.556 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 28,1M |
Ratio cours/bénéfice | -0,89 |
Ratio prix/ventes | 9,58 |
Ratio prix/liquidités | 2,57 |
Ratio prix/valeur comptable | -5,33 |
Rendement de dividende | - |
Actions en circulation | 8,7M |
Volume moyen (1 semaine) | 22,16k |
Volume moyen (1 mois) | 59,84k |
Variation sur 52 semaines | -16,13% |
Plus haut sur 52 semaines | 7,56 |
Plus bas sur 52 semaines | 2,6703 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales